1. Home
  2. BHST vs CYBN Comparison

BHST vs CYBN Comparison

Compare BHST & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHST
  • CYBN
  • Stock Information
  • Founded
  • BHST 2007
  • CYBN 2019
  • Country
  • BHST Canada
  • CYBN Canada
  • Employees
  • BHST N/A
  • CYBN N/A
  • Industry
  • BHST
  • CYBN Pharmaceuticals and Biotechnology
  • Sector
  • BHST
  • CYBN Health Care
  • Exchange
  • BHST Nasdaq
  • CYBN Nasdaq
  • Market Cap
  • BHST 166.4M
  • CYBN 176.5M
  • IPO Year
  • BHST N/A
  • CYBN N/A
  • Fundamental
  • Price
  • BHST $7.43
  • CYBN $6.53
  • Analyst Decision
  • BHST Strong Buy
  • CYBN Strong Buy
  • Analyst Count
  • BHST 2
  • CYBN 3
  • Target Price
  • BHST $13.00
  • CYBN $85.00
  • AVG Volume (30 Days)
  • BHST 21.0K
  • CYBN 575.1K
  • Earning Date
  • BHST 08-11-2025
  • CYBN 08-13-2025
  • Dividend Yield
  • BHST N/A
  • CYBN N/A
  • EPS Growth
  • BHST N/A
  • CYBN N/A
  • EPS
  • BHST N/A
  • CYBN N/A
  • Revenue
  • BHST $30,192,000.00
  • CYBN N/A
  • Revenue This Year
  • BHST $116.40
  • CYBN N/A
  • Revenue Next Year
  • BHST $55.91
  • CYBN N/A
  • P/E Ratio
  • BHST N/A
  • CYBN N/A
  • Revenue Growth
  • BHST 57.83
  • CYBN N/A
  • 52 Week Low
  • BHST $4.66
  • CYBN $4.81
  • 52 Week High
  • BHST $9.90
  • CYBN $13.88
  • Technical
  • Relative Strength Index (RSI)
  • BHST 39.26
  • CYBN 42.51
  • Support Level
  • BHST $7.10
  • CYBN $5.81
  • Resistance Level
  • BHST $9.45
  • CYBN $6.73
  • Average True Range (ATR)
  • BHST 0.50
  • CYBN 0.51
  • MACD
  • BHST -0.21
  • CYBN -0.06
  • Stochastic Oscillator
  • BHST 13.47
  • CYBN 34.78

About BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

Share on Social Networks: